Telitacicept for PGNMID: A Single-Arm Study
Clinical trial NCT07111338 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07111338
- Sponsor
- Peking University First Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-12
- Primary completion
- 2027-05-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.